Kathryn L. Biberstein
Directeur/Membre du Conseil chez Meridian Stories
Provenance du réseau au premier degré de Kathryn L. Biberstein
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
28
| Public Company | Pharmaceuticals: Major | 28 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
11
| Extinct | Pharmaceuticals: Major | 11 |
Crowell & Moring LLP
 Crowell & Moring LLP Miscellaneous Commercial ServicesCommercial Services Crowell & Moring LLP provides legal services. It offers litigation and arbitration, regulatory, and transactional matters. The firm serves the aerospace and defense, automotive and trucking, aviation, chemicals, education, energy, financial institutions, and government contracting industries. The company was founded in 1979 and is headquartered in Washington, DC.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kathryn L. Biberstein via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Investor Relations Contact Chief Operating Officer Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President Founder Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| University College Dublin | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Wellesley College | College/University | Corporate Officer/Principal Undergraduate Degree | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Elan Drug Technologies
 Elan Drug Technologies Pharmaceuticals: OtherHealth Technology Part of Perrigo Co. Plc, Elan Drug Technologies is an Irish company that manufactures and distributes drugs. The company is based in Athlone, Ireland. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree | |
LZ Therapeutics, Inc.
 LZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LZ Therapeutics, Inc. develops novel differentiated products for the treatment of neurological disorders. It provides therapeutics to improve patient outcomes, including improved symptom control and potential disease modification. The company was founded by Jay S. Schneider in 2005 and is headquartered in Chester, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Graduate Degree | |
| Bentley University | College/University | Undergraduate Degree Director/Board Member | |
| Vimela Therapeutics Ltd. | Director/Board Member | ||
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member | |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom. | Biotechnology | Director/Board Member | |
Kymo Therapeutics Ltd.
 Kymo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kymo Therapeutics Ltd. develops and commercializes therapeutic products . The company was founded on May 23, 2016 and is headquartered in Hatfield, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Kaerus Bioscience Ltd. | Director/Board Member | ||
Mavalon Therapeutics Ltd.
 Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Mavalon Therapeutics Ltd. develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients. The company is headquartered in Hatfield, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Nira Biosciences, Inc. | Director/Board Member | ||
| Medicxi Ventures (Jersey) Ltd. (Switzerland) | Corporate Officer/Principal | ||
| ALDENA THERAPEUTICS, INC. | Director/Board Member | ||
| University of Bocconi | College/University | Undergraduate Degree | |
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Villaris Therapeutics, Inc. is an asset-centric biopharmaceutical company. The company is based in Cary, NC. The company was founded in 2019 by John Harris. The CEO is Andrea Epperly. | Pharmaceuticals: Major | Director/Board Member | |
Kaerus Bioscience France SASU
 Kaerus Bioscience France SASU Miscellaneous Commercial ServicesCommercial Services Kaerus Bioscience France SASU engages in research and development in biotechnology. The company was founded on February 23, 2017 and is headquartered in Orléans, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
| Pega-One SAS | Director/Board Member | ||
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
| Pearl River Bio GmbH | Director/Board Member | ||
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Stx Pharma Ltd. | Director/Board Member | ||
| Neumann University | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 23 |
| Royaume-Uni | 7 |
| France | 6 |
| Irlande | 5 |
| Suisse | 5 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 132 |
| Corporate Officer/Principal | 90 |
| Independent Dir/Board Member | 34 |
| Undergraduate Degree | 30 |
| Chief Tech/Sci/R&D Officer | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michèle Ollier | 40 |
| Floyd E. Bloom | 26 |
| Nancy Wysenski | 20 |
| Mark B. Skaletsky | 18 |
| Nancy Snyderman | 18 |
| Gerri Henwood | 16 |
| Shane Cooke | 13 |
| Peter Thornton | 13 |
| Srdjan Stankovic | 11 |
| Julio Casoy | 11 |
| Elliot Ehrich | 10 |
| Stuart R. Grant | 10 |
| William Daniel | 10 |
| Xiao Bing Li | 9 |
| Lisa von Moltke | 9 |
- Bourse
- Insiders
- Kathryn L. Biberstein
- Connexions Sociétés
